secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2022-08-08T23:59:59+00:00
Accession:  0001773751-22-000162
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers Q2 revenue $113.6M (+87% YoY); raises FY22 revenue guidance to $470-485M
--------------------------------------------------------------------------------

- Revenue of $113.6M, up 87% YoY; net loss $(19.7M) vs $(9.2M) prior year.
- Quarterly net new subscriptions >100k, total subscriptions 817k, up 80% YoY.
- Raises FY22 revenue guidance to $470-485M and Adjusted EBITDA guidance to $(27)M-$(20)M.
- Gross margin 77% (78% prior year); expects Adjusted EBITDA profitability within next four quarters.
- Launched Hers mobile app and 6 new Wellness Essentials supplements for women.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000177375122000162/0001773751-22-000162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000177375122000162/hims-20220808.htm
  HTML page:      https://secwatch.observer/filing/0001773751-22-000162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer